Review
Nature Reviews Immunology 4, 762-774 (October 2004) | doi:10.1038/nri1457
Ido expression by dendritic cells: tolerance and tryptophan catabolism
Andrew L. Mellor1 About the author & David H. Munn1
Abstract
Indoleamine 2,3-dioxygenase (IDO) is an enzyme that degrades the essential amino acid tryptophan. The concept that cells expressing IDO can suppress T-cell responses and promote tolerance is a relatively new paradigm in immunology. Considerable evidence now supports this hypothesis, including studies of mammalian pregnancy, tumour resistance, chronic infections and autoimmune diseases. In this review, we summarize key recent developments and propose a unifying model for the role of IDO in tolerance induction.
- View At a Glance
Author affiliations
- Program in Molecular Immunology, Institute of Molecular Medicine and Genetics, Departments of Medicine and Pediatrics, Medical College of Georgia, Augusta, Georgia 30912, USA.
Correspondence to: Andrew L. Mellor1 Email: amellor@mail.mcg.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
When ligand becomes receptor?tolerance via B7 signaling on DCsNature Immunology News and Views (01 Nov 2002)
CD28-B7 bidirectional signaling: a two-way street to activationNature Immunology News and Views (01 Nov 2004)
See all 3 matches for News And ViewsRESEARCH
A GTP-binding adapter protein couples TRAIL receptors to apoptosis-inducing proteinsNature Immunology Article (01 Jun 2001)
See all 33 matches for Research
